Cardiocell LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://stemcardiocell.com
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
Phase 2
Completed
- Conditions
- Non-Ischemic Heart Failure
- Interventions
- Drug: Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)Drug: Lactated Ringer's Solution
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- CardioCell LLC
- Target Recruit Count
- 23
- Registration Number
- NCT02467387
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸Northwestern University Centers for Heart Failure Therapy, Chicago, Illinois, United States
🇺🇸Hospital of the University of Pennsylvania, Heart Failure and Transplant Program, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath